These outcomes, along with a prior report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the concept of targeting ACKR3 as a novel approach to modulate the opioid process, which could open new therapeutic avenues for opioid-related Ailments. Morphine as well as other opioids https://fredl924egy4.wikibyby.com/user